A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab
Simon Francis Thomsen
Abstract
Simon Francis Thomsen
Abstract
"A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab." Journal of Dermatological Treatment, 29(8), pp. 823–824
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
"A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab." Journal of Dermatological Treatment, 29(8), pp. 823–824
Key concepts: Hidradenitis suppurativa, Dermatology Life Quality Index, Medicine, Adalimumab, Dermatology, Quality of life (healthcare), Psoriasis, Internal medicine